226 related articles for article (PubMed ID: 32947996)
1. Suppression of Oxidative Stress as Potential Therapeutic Approach for Normal Tension Glaucoma.
Harada C; Noro T; Kimura A; Guo X; Namekata K; Nakano T; Harada T
Antioxidants (Basel); 2020 Sep; 9(9):. PubMed ID: 32947996
[TBL] [Abstract][Full Text] [Related]
2. Regulatory mechanisms of retinal ganglion cell death in normal tension glaucoma and potential therapies.
Shen WC; Huang BQ; Yang J
Neural Regen Res; 2023 Jan; 18(1):87-93. PubMed ID: 35799514
[TBL] [Abstract][Full Text] [Related]
3. ASK1 deficiency attenuates neural cell death in GLAST-deficient mice, a model of normal tension glaucoma.
Harada C; Namekata K; Guo X; Yoshida H; Mitamura Y; Matsumoto Y; Tanaka K; Ichijo H; Harada T
Cell Death Differ; 2010 Nov; 17(11):1751-9. PubMed ID: 20489729
[TBL] [Abstract][Full Text] [Related]
4. Targeting Oxidative Stress for Treatment of Glaucoma and Optic Neuritis.
Kimura A; Namekata K; Guo X; Noro T; Harada C; Harada T
Oxid Med Cell Longev; 2017; 2017():2817252. PubMed ID: 28270908
[TBL] [Abstract][Full Text] [Related]
5. Autophagy in axonal degeneration in glaucomatous optic neuropathy.
Munemasa Y; Kitaoka Y
Prog Retin Eye Res; 2015 Jul; 47():1-18. PubMed ID: 25816798
[TBL] [Abstract][Full Text] [Related]
6. The potential role of glutamate transporters in the pathogenesis of normal tension glaucoma.
Harada T; Harada C; Nakamura K; Quah HM; Okumura A; Namekata K; Saeki T; Aihara M; Yoshida H; Mitani A; Tanaka K
J Clin Invest; 2007 Jul; 117(7):1763-70. PubMed ID: 17607354
[TBL] [Abstract][Full Text] [Related]
7. Valproic acid prevents retinal degeneration in a murine model of normal tension glaucoma.
Kimura A; Guo X; Noro T; Harada C; Tanaka K; Namekata K; Harada T
Neurosci Lett; 2015 Feb; 588():108-13. PubMed ID: 25555796
[TBL] [Abstract][Full Text] [Related]
8. DRP1 inhibition rescues retinal ganglion cells and their axons by preserving mitochondrial integrity in a mouse model of glaucoma.
Kim KY; Perkins GA; Shim MS; Bushong E; Alcasid N; Ju S; Ellisman MH; Weinreb RN; Ju WK
Cell Death Dis; 2015 Aug; 6(8):e1839. PubMed ID: 26247724
[TBL] [Abstract][Full Text] [Related]
9. Transneuronal Degeneration in the Brain During Glaucoma.
You M; Rong R; Zeng Z; Xia X; Ji D
Front Aging Neurosci; 2021; 13():643685. PubMed ID: 33889083
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of the endothelin A (ET
McGrady NR; Minton AZ; Stankowska DL; He S; Jefferies HB; Krishnamoorthy RR
BMC Neurosci; 2017 Mar; 18(1):27. PubMed ID: 28249604
[TBL] [Abstract][Full Text] [Related]
11. [Glutamate receptor-mediated retinal neuronal injury in experimental glaucoma].
Wang ZF; Yang XL
Sheng Li Xue Bao; 2016 Aug; 68(4):483-91. PubMed ID: 27546508
[TBL] [Abstract][Full Text] [Related]
12. Arundic acid attenuates retinal ganglion cell death by increasing glutamate/aspartate transporter expression in a model of normal tension glaucoma.
Yanagisawa M; Aida T; Takeda T; Namekata K; Harada T; Shinagawa R; Tanaka K
Cell Death Dis; 2015 Mar; 6(3):e1693. PubMed ID: 25789968
[TBL] [Abstract][Full Text] [Related]
13. Carvedilol Promotes Retinal Ganglion Cell Survival Following Optic Nerve Injury via ASK1-p38 MAPK Pathway.
Liu B; Liu YJ
CNS Neurol Disord Drug Targets; 2019; 18(9):695-704. PubMed ID: 31577210
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-1 attenuates normal tension glaucoma-like retinal degeneration in EAAC1-deficient mice.
Namekata K; Harada C; Guo X; Kikushima K; Kimura A; Fuse N; Mitamura Y; Kohyama K; Matsumoto Y; Tanaka K; Harada T
Neurosci Lett; 2009 Nov; 465(2):160-4. PubMed ID: 19766171
[TBL] [Abstract][Full Text] [Related]
15. [Aiming for zero blindness].
Nakazawa T
Nippon Ganka Gakkai Zasshi; 2015 Mar; 119(3):168-93; discussion 194. PubMed ID: 25854109
[TBL] [Abstract][Full Text] [Related]
16. Critical role of Nrf2 in oxidative stress-induced retinal ganglion cell death.
Himori N; Yamamoto K; Maruyama K; Ryu M; Taguchi K; Yamamoto M; Nakazawa T
J Neurochem; 2013 Dec; 127(5):669-80. PubMed ID: 23721546
[TBL] [Abstract][Full Text] [Related]
17. Caloric restriction promotes cell survival in a mouse model of normal tension glaucoma.
Guo X; Kimura A; Azuchi Y; Akiyama G; Noro T; Harada C; Namekata K; Harada T
Sci Rep; 2016 Sep; 6():33950. PubMed ID: 27669894
[TBL] [Abstract][Full Text] [Related]
18. Retinal ganglion cells downregulate gene expression and lose their axons within the optic nerve head in a mouse glaucoma model.
Soto I; Oglesby E; Buckingham BP; Son JL; Roberson ED; Steele MR; Inman DM; Vetter ML; Horner PJ; Marsh-Armstrong N
J Neurosci; 2008 Jan; 28(2):548-61. PubMed ID: 18184797
[TBL] [Abstract][Full Text] [Related]
19. Gene therapy for retinal ganglion cell neuroprotection in glaucoma.
Wilson AM; Di Polo A
Gene Ther; 2012 Feb; 19(2):127-36. PubMed ID: 21975466
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotection, Growth Factors and BDNF-TrkB Signalling in Retinal Degeneration.
Kimura A; Namekata K; Guo X; Harada C; Harada T
Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27657046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
